Ultime Pubblicazioni
2011 |
Role of Immediate-Release Morphine (MIR) in the Treatment of Predictable Pain in Radiotherapy P. Murino, M. Mammucari, D. Borrelli, A. Pepe, M. F. Giugliano, A. Morra,G. Panelli, R. Manzo, V. Ravo, and P. Muto Journal of Pain & Palliative Care Pharmacotherapy. 2011;25:121–124 Exclusive Radiotherapy Of Prostatecancer With Helical Tomotherapy: Initial Experience Fabrizio Cammarota. Diego Toledo, Domenico Borrelli,Matteo Muto, Luciano Savuto and Paolo Muto. Abstracts of the 2/st Annua/ Meeting of the halian Society of C/ro-Onco/ogy (SlUrO), 22-24 /une, 2011, Naples, Italy The Role Of Image-Guided Radiotherapy In Preventing Urinary And Rectal Toxicities In Patients With Prostate Cancer Treated With Radiotherap Vincenzo Ravo. Roberto Manzo, Cammarota Fabrizio,Murino Paola, Muto Paolo, Calvanese Mariagrazia, Cuomo Mariagrazia, Lepone Fabio, Nicolucci Giovanni, Crisci Vincenzina and Difranco Rosella ANTICANCER RESEARCH 31:1807-1956 (2011) Tomotherapy In Postoperative Patients With Prostate Cancer Evaluation Of Acute Toxicity Domenico Borrelli, Diego Toledo, Fabbrizio Cammarota, Matteo Muto and Paolo Muto. Abstracts of the 21 st Annual Meeting of the Italian Society of Uro-Oncology (SlUrO), 22-24 June, 2011, Naples, Italy Bisphosphonates: molecular basis and clinical evidences Roberto Orecchia, Sara Ramella, Giovanni Mandoliti, Lucio Trodella, Paolo Muto. I supplementi di Tumori, vol. 12,No 3: S1-S6, 2011 Integrating radiation therapy and bisphosphonates Giovanni Mandoliti, Sara Ramella, Paolo Muto, Roberto Orecchia, Lucio Trodella. I supplementi di Tumori, vol. 12,No 3: S7-S11, 2011 Radiation therapy for bone metastases Lucio Trodella, Sara Ramella, Rolando Maria D’Angelillo, Roberto Orecchia, Paolo Muto, Giovanni Mandoliti. I supplementi di Tumori, vol. 12, No 3: S12-S17, 2011 The multidisciplinary management of patient with bone metastases Palo Muto, Sara Ramella, Sara Falivene, Lucio Trodella, Giovanni Mandoliti, Roberto Orecchia. I supplementi di Tumori, vol. 12,No 3: S18-S21, 2011 Prevention of cutaneous damages induced by radiotherapy in breast cancer: an institutional experience Vincenzo Ravo, Maria Grazia Calvanese, Rossella Di Franco, Vincenzina Crisci, Paola Murino, Roberto Manzo, Anna Morra, Fabrizio Cammarota, and Paolo Muto. Tumori, 97: 732-736, 2011 POSTER E COMUNICAZIONI PRESENTATI AL XXI CONGRESSO NAZIONALE DI RADIOTERAPIA A GENOVA NOVEMBRE 2011RELEVANCE OF DEFENSIVE MEDICINE PHENOMENON AMONG CAMPANIA’S RADIATION ONCOLOGISTS G. Guida, B. Pecori1, G. De Palma, V. Ravo, R. Pacelli, C. Guida, A. Pepe, S. Falivene, F. Lanza, L. Starace, M. Mormile, P. Muto PSYCHO-ONCOLOGY COUNSELLING IN RADIOTHERAPY G. Silvestro, F. De Falco, L. Palmisciano, C. Noviello, V. Manera, G. Guida, P. Muto. TREATMENT RESULTS OF CHEMORADIOTHERAPY WITH FOLFOX 4 REGIMEN IN HIGH RISK GASTRIC CANCER – P. Murino, R. Manzo, M. Ordituran, S. Falivene, C. Crisci, R. Di Franco, M.G. Calvanese, F. Cammarota, P. Muto, V. Ravo. REGIONAL FAILURE RATES IN SELECTED PN1 HEAD AND NECK CARCINOMA TREATED WITH SELECTIVE NECK DISSECTION AND POSTOPERATIVE RADIATION THERAPY AT T LEVEL: PRELIMINARY RESULTS. R. Manzo, P. Murino, L. Leopaldi, F.M. Giugliano, G. Nicolucci, G. Colella, A. Gambardella, G. Tortoriello, P. Muto, V. Ravo IRRADIATION WITH LINAC AND HELICAL TOMOTHERAPY IN PATIENTS WITH STAGE I SEMINOMA AFTER ORCHIECTOMY: A TECHNICAL COMPARISON D. Toledo, D. Borrelli, M. Muto, G. Panelli, A. Pepe,F. Cammarota, P. Muto. HI ART TOMOTHERAPY FOR THE TREATMENT OF THE MELANOMA OF THE SOFT PALATE: A CASE REPORT D. Borrelli, D. Toledo, M. Muto, G. Panelli, A. Pepe, F. Cammarota, P. Muto. TOMOTHERAPY IRRADIATION IN PATIENTS WITH RHABDOMYOSARCOMA OF THE HEAD AND NECK: TWO CASE REPORT D. Toledo, D. Borrelli, M. Muto, G. Panelli, A. Pepe,F. Cammarota, P. Muto. TOMOTHERAPY IN POSTOPERATIVE PATIENTS WITH PROSTATE CANCER: EVALUATION OF ACUTE TOXICITY D. Borrelli, D. Toledo, M. Muto, G. Panelli, A. Pepe,F. Cammarota, P. Muto IGRT WITH CONE-BEAM CT FOR PROSTATIC CANCER. CAN WE REDUCE PTV’S MARGINS? M.G. Calvanese, F. Lepone, R. Manzo, P. Murino, F. Cammarota, P. Muto, V. Ravo. CRANIOSPINAL IRRADIATION WITH HI-ART TOMOTHERAPY IN PATIENTS WITH MEDULLOBLASTOMA IN ADULTS: ACUTE TOXICITY D. Borrelli, D. Toledo, M. Muto, G. Panelli, A. Pepe,F. Cammarota, P. Muto USE OF ADJUVANT THERAPY IN PATIENTS WITH FIGO STAGE III ENDOMETRIAL CARCINOMA: A MULTICENTER RETROSPECTIVE STUDY G. Silvestro, C. Marchetti, C. Pisano, G. Mangili, D. Lorusso, P. Benedetti Panici, M. Petrone, S.Greggi, M. Di Maio, P. Muto, S. Pignata TOMOTHERAPY IRRADIATION IN PATIENTS WITH BRAIN LYMPHOMA: ACUTE TOXICITY. D. Borrelli, D. Toledo, M. Muto, G. Panelli, A. Pepe,F. Cammarota, P. Muto. TOMOTHERAPY IRRADIATION IN PATIENTS WITH LYMPHOMA LOCALIZED IN THE HEAD AND NECK: ACUTE TOXICITY . D. Toledo, D. Borrelli, M. Muto, G. Panelli, A. Pepe,F. Cammarota, P. Muto. MULTIDISCIPLINARY MANAGEMENT OF PAINFUL BONE METASTASES: THE INTERACTION BETWEEN RADIATION THERAPY AN ZOLEDRONATE. R. Di Franco, V. Crisci, M.G. Cuomo, P. Murino,R. Manzo, P. Muto, S. Cappabianca, V. Ravo. THE EFFECT OF MODIFIED DOSE FRACTIONATION IN NON SMALL CELL LUNG CANCER. P. Pedicini, L. Strigari, M. Benassi, R. Caivano, G. Califano, V. Barbieri, P. Sanpaolo, A. Fiorentino, G. Castaldo, A. Morra, V. Ravo, P. Muto, V. Fusco,R. Orecchia. RADIATION THERAPY IN THYMOMA: CAMPANIA’S MULTICENTRIC EXPERIENCE. D. Alberti, V. Ravo, S. Falivene, M. Muto, D. Toledo, A. Pepe, P. Muto. MANAGEMENT OF RADIATION INJURIES OF THE VAGINA. G. Silvestro, V. Manera, G. De Palma, B. Pecori, F. Lanza, S. Falivene, S. Greggi, S. Pignata, P. Muto. |
|
2010 |
Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy Roberto Manzo, Vincenzo Ravo, Paola Murino, Anna Morra, Giuseppe Panetti, Antonio Laudati, Agnese Prisco, Giancarlo Panelli and Paolo Muto Tumori, 96: 577-581, 2010 Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F, Avuzzi B, Buscarini E, Fornasarig M, Iacono C, Maiero S, Mosconi S, Muto P, Tasca C, Vanin V. Dig Liver Dis. 2010 Dec;42(12):831-8. Epub 2010 Aug Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study. Orditura M, De Vita F, Muto P, Vitiello F, Murino P, Lieto E, Vecchione L, Romano A, Martinelli E, Renda A, Ferraraccio F, Del Genio A, Ciardiello F, Galizia G. Arch Surg. 2010 Mar;145(3):233-8 Patterns of Care and Survival in a Retrospective Analysis of 1059 Patients With Glioblastoma Multiforme Treated Between 2002 and 2007: A Multicenter Study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology) Silvia Scoccianti, Stefano Maria Magrini, Umberto Ricardi, Beatrice Detti, Michela Buglione, Guido Sotti, Marco Krengli, Sergio Maluta, Salvatore Parisi, Filippo Bertoni, Cristina Mantovani, Vincenzo Tombolini, Costantino De Renzis, Marco Lioce, Lucia Fatigante, Vincenzo Fusco, Paolo Muto, Franco Berti, Giovanni Rubino, Samantha Cipressi, Laura Fariselli, Marco Lupattelli, Riccardo Santoni, Luigi Pirtoli, Giampaolo Biti Neurosurgery, 2010 vol. 67, no2, pp. 446-458 Presidio Ascalesi: Eccellenza nel reparto di Radioterapia F.Cammarota, V.Ravo, Paolo Muto TECNICA OSPEDALIERA settembre 2010, pag 90-95 Multimodality treatment of locally advanced soft-tissue sarcomas of the extremities Vincenzo Ravo, Immacolata Marronea, Anna Morra, Roberto Manzo, Paola Murino, Fabrizio Cammarota, Paolo Muto. Reports of Practical Oncology & Radiotherapy Vol 15, Issue 5, September-October 2010, Pages 119-124 Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: Report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties. Crit Rev Oncol Hematol. 2010 Jun 23 AROME Workingparties(WP)members:BreastancervixcancersWP:JosephGligorov(Chair;France),OliverArsovski(Macedonia);YazidBelkacemi(France),MounirBachouchi(Morocco); FrederiquePenault-Llorca(France); Marie-PierreChauvet(France);NuranSenel Bese(Turkey);MariaCarlaValli(Italy).UrologycancersWP: HamoudaBoussen(Chair;Tunisia), AssemAlhalabi(Syria),AssiaBensalem(Algeria),MichelHery(Monaco),AgimSallaku(Albania),SalvadorVilla(Spain).GastrointestinalWP:MarcYchou(Chair;France),DavidAzria(France), KadaBoualga(Algeria),NoureddineBouaouina(Tunisia), LaurentCals(France),YoramCohen(Israel),FadyGeara(Lebanon),NikolaVasev(Macedonia), HaitamNasrallah(Israel).HeadandNeckcancersWP:MahmutOzsahin(Chair;TurkeySwitzerland),AbdelBenider(Morocco),KhaldounKerrou(France),DhurataKoroveshi(Albania), AbrahamKuten(Israel),PaoloMuto(Italy), KhaledThabet(PalestinianAuthority),VladimirTodorovic(Montenegro). LungcancerWP: KamelBouzid(Chair;Algeria),YanesBashar(PalestinianAuthoritySwitzerland),AlfredoCarrato(Spain),MladenFilipovic(Montenegro), CesareGridelli(Italy), NilMolinasMandel(Turkey), PelagiaG.Tsoutsou(Greece), AbderrahimZouhair(Morocco-Switzerland). CollaborativeProjectsWP:YazidBelkacemi(Chair;France),MichaBarHana(Israel), ZviBernstein(Israel), StelladeSabata(Italy), MokhtarHamdicherif(Algeria), FrancoisLokiec(France), MonderMahjoubi(Tunisia), HugoMarsiglia(Spain), YounesMahi(France-Algeria). Coordinationofthemanuscriptelaboration: JosephGligorov(France),PelagiaG.Tsoutsou(Greece), AbrahamKuten(Israel), HamoudaBoussen(Tunisia), FadyGeara(Lebanon), NuranBese(Turkey) ,YazidBelkacemi(France). Urinary and rectal toxicities of patients with prostate cancer treated with image guide radiotherapy (IGRT Cone beam CT) Robello A, Calvanese MG, Lanza F, Murino P, Manzo R, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 34 Evaluation of thyroid function in treatment of supra-clavicular region in patients affected by breast cancer. Robello A, Murino P, Manzo R, Cammarota F, Cuomo MG, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 64 Toxicity impact consequent to chemoradiotherapy in patients with locally advanced gastric cancer. Murino P, Robello A, Falivene S, Manzo R, Cammarota F, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 71 Primary oral malignant melanoma: case report. Murino P, Robello A, Falivene S, Manzo R, Cammarota F, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 92 Acute toxicity in radiation therapy on pleural malignant mesotelioma: Step&Shoot-IMRT vs Helical Tomotherapy. Cammarota F, Borrelli D, Marrone I, Toledo D, Muto M, Ravo V, Morra A, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 95 Induction chemotherapy followed by cetuximab plus definitive radiotherapy for locally advanced squamous cell carcinoma of the head and neck: a fase I study. Manzo R, Leopaldi L, Ravo V, Murino P, Giugliano FM, Robello A, Panetti G, Maiorino L, Castagna G, Barba G, Tortoriello G, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 107 Modulated dose fractionations in combined treatments by radiation and monolocal antibody in head and neck cancer. Pedicini P, Califano G, Caivano R, Fiorentino A, Barbieri V, Sanpaolo P, Castaldo G, Morra A, Ravo V, Muto P, Fusco V, Orecchia R. I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 110 Acute toxicity in patients with rectal cancer treated with neoadjuvant radiochemotherapy with oral malignant regimen (capecitabina). Falivene S, Murino P, Robello A, Manzo R, Lanza F, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 127 Primary results of magnetic resonance diffusion-weighted imaging (DWI-MR) in the evaluation of bone metastases before and after palliative radiotherapy. Giugliano FM, Nicolucci G, Manzo R, Murino P, Ravo V, Muto P, Cappabianca S. I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 138 To be a radiotherapist in 2010. Murino P, Robello A, Manzo R, Ravo V, D’Alterio V, Terracciano B, Alterio A, Giugliano FM, Falivene S, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 159 New challanages in radiation oncology. Giugliano FM, Manzo R, Nicolucci G, Murino P, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 196 Management of primary central nervous system lymphoma (PCNSL) in a patient with iatrogenic myopathy corticosteroid-related. Robello A, Manzo R, Falivene S, Murino P, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 213 Variability in delineation of treatment volumes for gastric cancer in 3D-CRT: our experience. Robello A, Murino P, Morra A, Manzo R, Cammarota F, Ravo V, Muto P I supplementi di Tumori: volume 10, numero 2, novembre 2010, p. 214 Adjuvant Chemoradiotherapy in Patients With Stage III or IV Radically Resected Gastric Cancer: A Pilot Study Orditura, Michele, De Vita, Ferdinando, Muto, Paolo,Vitiello, Fabiana, Murino, Paola Lieto, Eva Vecchione, Loredana Romano, Anna Martinelli, Erika Renda, Andrea Ferraraccio, Francesca Del Genio, Alberto Ciardiello, Fortunato Galizia, Gennaro Archives of Surgery, ISSN: 0004-0010, Vol: 145, Issue: 3, Date: 2010-01-01, Start page: 233, # of pages: 6 Role of Immediate-Release Morphine (MIR) in the Treatment of Predictable Pain in Radiotherapy P. Murino, M. Mammucari, D. Borrelli, A. Pepe, M. F. Giugliano, A. Morra,G. Panelli, R. Manzo, V. Ravo, and P. Muto Journal of Pain & Palliative Care Pharmacotherapy. 2011;25:121–124. |
|
2009 |
ADJUVANT CHEMORADIATION WITH BIWEEKLY OXALIPLATIN PLUS INFUSIONAL 5- FLOROURACIL AND FOLINIC ACID REGIMEN IN STAGE III-IV RADICALLY RESECTED GASTRIC CANCER PATIENTS : A PILOT STUDY Michele Orditura, Ferdinando De Vita, Paolo Muto, Fabiana Vitiello, Paola Murino, Eva Lieto, Loredana Vecchiona, Anna Romano, Erika Martinelli, Andrea Renda, Francesca Ferraraccio, Alberto Del Genio, Gennaro Galizia, Fortunato Ciardiello, Giuseppe Catalano. Annals of Oncology Supplement 8 11 th Nazionale di Oncologia Medica. Milano 10-13 Ottobre 2009.
ASTROBLASTOMA: A CASE REPORT R. Manzo, P. Murino, A. Robello, D. Toledo, C. Ascione, A. Morra, V. Ravo, P. Muto 58° Congresso Nazionale SINch. Lecce, 14-17 Ottobre 2009
HELICAL TOMOTHERAPY IN THE ADMINISTRATION OF SIB IN THE HEAD AND NECK TUMORS, THE TECHNICAL DIFFICULTIES IN CASES OF OUR EXPERIENCE Francomacaro F., Cammarota F.,BorrelliD., Robello A. Morra A., Ravo V., Muto P. XIX Congresso Nazionale AIRO Bologna, 14-17 Novembre 2009
URINARY INCONTINENCE IN PATIENTS TREATED WITH RADIOTHERAPY AFTER PROSTATECTOMY Robello A., Morra A., Ravo V.,Murino P.,Manzo R.,Ascione C.,Cuomo M.G.,Toledo D.,Cammarota F.,Muto P. XIX Congresso Nazionale AIRO Bologna, 14-17 Novembre 2009
SACRAL CHORDOMA : A CASE REPORT Pepe A., Panelli G., Cammarota F., Muto M., Borrelli D., Muto P. XIX Congresso Nazionale AIRO Bologna, 14-17 Novembre 2009
HYPOTHYROIDSM INDUCED BY EXTERNAL BEAM RADIATION THERAPY ON PEDIATRIC PATIENT AFFECTED BY MEDULLOBLASTOMA: DEPENDENCE ON THE IRRADIATION TECHNIQUE Cammarota F., Francomacaro F., Migliorati R., Panelli G., Pepe A., Muto M., Borrelli D., Muto P. XIX Congresso Nazionale AIRO Bologna, 14-17 Novembre 2009
LONG TERM SIDE EFFECTS OF RADIOTHERAPY FOR BRAIN TUMORS IN PEDIATRIC PATIENTS Giugliano F.M., Murino P., Manzo R., Panelli G., Morra A., Ravo V., Pepe A., Migliorati R., Muto P. XIX Congresso Nazionale AIRO Bologna, 14-17 Novembre 2009
PAIN MANAGEMENT IN PATIENTS WITH BONE METASTASES: RESULTS OBTAINED WITH BONE METASTASES: RESULTS OBTAINED WITH ADMINISTRATION OF MORPHINE SULPHATE Murino P., Manzo R., Ascione C., Giugliano F.M., Cuomo M.G., Nicolucci G., Robello A., Morra A., Ravo V., Muto P. XIX Congresso Nazionale AIRO Bologna, 14-17 Novembre 2009 |
|
2008 |
SUB-UNITA’ FUNZIONALI IN SERIE E IN PARALLELLO: EFFETTO DELLA MODIFICA DEL FRAZIONAMENTO IN RADIOTERAPIA Pedicini P., Manzo R., Fusco V., Ravo V., Muto P. Radiazioni –Ricerca e Applicazioni- Vol. XI n1/2008
COMPLICATION AFTER MASTECTOMY: TWO COMPARED TECNIQUES Marrone I, Macrì S.,Borrelli D.,Ravo V., Cammarota F., Morra A., Manzo R., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
IMPACT OF SYMPTOMS OF THE PHASE OF FILLING OF BLADDER AND POST MICTURITION ON THE QUALITY OF LIFE IN PATIENTS SUFFERING FROM PROSTATE CANCER TREATED WITH 3D-CRT Robello A. , Ravo V ., Morra A., Cuomo M., Pedicini P., Manzo R.. Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
IMPACT OF QOL OF TREATMENT OF BONES METASTASES WITH RADIOTHERAPY Robello A., Ascione C.,Toledo D. , Giugliano F.M, Murino P., Manzo R., Ravo V., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
BONE METASTASIS TREATMENT WITH VERTEBROPLASTY AND RADIATION THERAPY: RESULTS OBTAINED IN 180 PATIENTS Manzo R., Muto M., Guarnieri G., Murino P., Zeccolini F., Morra A., Ravo V., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
EVALUATION OF PATIENTS COMPLIANCE WITH BONE METASTASIS AFTER ADMINISTRATION OF MORPHINE SULFATE IN RADIOTHERAPIC MANAGEMENT Ascione C., Robello A., Toledo D., Giugliano F.M., Murino P., Manzo R., Ravo V., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
HAS CERB A ROLE IN DUCTAL CARCINOMA IN SITU? Marrone I., Borrelli D., Ravo V., Panelli G., Morra A., Francomacaro F., Manzo R., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
INTEGRATION OF MEDICAL TREATMENTS : RADIOTHERAPY AND PSYCOLOGICAL INTERVENTION IN RELATION WITH A CANCER PATIENT UNDERGOING 3D-CONFORMAL RADIOTHERAPY TREATMENT Morra A., Auriemma G., Ferro S., Geri G., Ravo V., Manzo R., Murino P., Borrelli D., Marrone I.,Cuomo M.G., Russo M., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
COMUNICATION AMONG PHYSICIAN, PSYCHOLOGIST, SOCIAL ASSISTANT AND PATIENT IN THEWAITING ROOM OF A DEPARTMENT OF RADIOTHERAPY XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
COMUNICATION AMONG PHYSICIAN, PSYCHOLOGIST, SOCIAL ASSISTANT AND PATIENT IN THE WAITING ROOM OF A DEPARTMENT OF RADIOTHERAPY Murino P., Robello A., Toledo D., Ascione C., Manzo R., Morra A., Ravo V., Alterio A., Terracciano B., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
IMPACT OF WHOLE BRAIN RADIOTHERAPY OF QOL OF PATIENTS WITH BRAIN METASTASIS Robello A., Toledo D., Ascione C., Giugliano F.M., Nicolucci G., Murino P., Manzo R., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
ASTROBLASTOMA: A CASE REPORT Murino P., Robello A.,Toledo D., Ascione C., Manzo R., Pepe A., Morra A. , Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008
DVH AND IPSS. INDIVIDUALIZATION OF THE SUBJECTS AT RISK OF DYSURIA IN PROSTATE CANCER RADIOTHERAPY Robello A., Cuomo M., Morra A., Manzo R., Cammarota F., Pedicini P., Ravo V., Muto P. XVIII Congresso Nazionale AIRO Milano, 15-18 Novembre 2008 |
|
2007 |
Chemoradiotherapy as adjuvant treatment of gastric cancer. Orditura M, Martinelli E, Galizia G, Vitiello F, Fasano M, Muto P, Ciardiello F, De Vita F. Ann Oncol. 2007 Jun;18 Suppl 6:vi133-5.
NEURORADIOSURGERY AND STEREOTACTIC RADIOTHERAPY: sTATE OF THE ART AND FUTURE DEVELOPMENTS P.Muto, R. Manzo Rivista Medica 13, (1) 2007:251-254
THE PATTERNS OF FAILURE FOR NASOPHARINGEAL CARCINOMA TREATED WITH RADIOCHEMOTHERAPY: A RETROSPECTIVE ANALYSIS Ferro A.,Gaetano M.,Panelli G.,Ascione C.,Manzo R., Muto P. XVII Congresso Nazionale AIRO Firenze, 10-13 Novembre 2007
STATISTICAL APPRAISAL OF PATIENT ERROR SET-UP IN THE VISULA COMPARISON BETWEEN THE PORTA IMAGE AND THE DIGITAL RECONSTRCTED RADIOGRAPHY (DRR) Pedicini P., Cammarota F., Francomacaro F.,Manzo R., Muto P. XVII Congresso Nazionale AIRO Firenze, 10-13 Novembre 2007 PATIENT POSITIONING IN BRAIN STEREOTACTIC RADIOTHERAPY: EFFICIENCY EVALUATION FOR A COMMERCIAL IR SYSTEMCammarota F.,Pedicini P.,Manzo R., Francomacaro F., Muto P. XVII Congresso Nazionale AIRO Firenze, 10-13 Novembre 2007
CONCOMITANT RADIO-CHEMIOTHERAPY WITH FOLFOX 6 REGIMEN AFTER POTENTIALLY CURATIVE SURGERY IN LOCALLY ADVANCED GASTRIC CANCER PATIENT Borrelli D., Prisco A., Marrone I.,Murino P., Morra A., Ravo V.,Manzo R., Pedicini P.,Orditura M.,Muto P. XVII Congresso Nazionale AIRO Firenze, 10-13 Novembre 2007
RADIO-CHEMIOTHERAPY FOR TREATMENT OF GLIOBLASTOMA MULTIFORME:OUTCOMES IN TERMS OF TOXICITY,DISEASE-FREE SURVIVALL AND OVERALL SURVIVAL Manzo R.,Pepe A., Robello A.,Panelli G., Prisco A., Pedicini P., Muto P. XVII Congresso Nazionale AIRO Firenze, 10-13 Novembre 2007
OUTCOMES AND TOXICITY OF RADIATION THERAPY FOR T1 GLOTTIC CARCINOMA Manzo R.,Panetti G., Laudati A.,Prisco A.,Panelli G., Muto P. XVII Congresso Nazionale AIRO Firenze, 10-13 Novembre 2007
|
|
2006 |
Phase I study of temozolomide and lomustine in the treatment of high grade malignant glioma Tafuto S, Muto P, Tortoriello A, Pisano A, Comella P, Formato R, Quattrin S, Iaffaioli RV. Front Biosci. 2006 Jan 1;11:502-5.
“Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer.” Turitto G, Panelli G, Frattolillo A, Auriemma A, De Luna FS, Cione G, De Angelis CP, Muto P, Iaffaioli RV. Front Biosci. 2006 May 1;11:1275-9 |
|
2004 |
RADIOTHERAPY OF SKIN CANCER Paolo Muto XIV Congresso nazionale AIRO, Torino 17-20 Ottobre 2004
EXTRACRANIAL HYPOFRACTIONATED STEREOTACTIC ARC RADIOTHERAPY: A 4 YEARS EXPERIENCE Muto P., Panelli G., Macrì S.C. XIV Congresso nazionale AIRO, Torino 17-20 Ottobre 2004
NEOADJUVANT CONCURRENT RADIO-CHEMOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER Muto P., Panelli G., Turitto G., Frattolillo A., Auriemma A., Salzano F., Cione G., De Angelis C.P., Iaffaioli R.V. XIV Congresso nazionale AIRO, Torino 17-20 Ottobre 2004 |